The estimated Net Worth of Glenn Mc Dowell is at least $12.5 Million dollars as of 31 August 2021. Mr. Dowell owns over 6,202 units of U.S. Physical Therapy stock worth over $1,152,070 and over the last 20 years he sold USPH stock worth over $9,850,716. In addition, he makes $1,463,960 as Chief Operating Officer - West at U.S. Physical Therapy.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. McDowell USPH stock SEC Form 4 insiders trading
Glenn has made over 28 trades of the U.S. Physical Therapy stock since 2005, according to the Form 4 filled with the SEC. Most recently he sold 6,202 units of USPH stock worth $727,495 on 31 August 2021.
The largest trade he's ever made was exercising 34,000 units of U.S. Physical Therapy stock on 7 March 2011 worth over $476,340. On average, Glenn trades about 5,223 units every 140 days since 2005. As of 31 August 2021 he still owns at least 13,867 units of U.S. Physical Therapy stock.
You can see the complete history of Mr. Dowell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Glenn McDowell biography
Glenn D. McDowell is no longer serves as Chief Operating Officer - West of the Company effective 8/31/2021. Commencing as of March 5, 2018, Mr. McDowell’s title was modified to Chief Operating Officer — West. Mr. McDowell served as our Vice President of Operations overseeing the west region since joining us in October 2003 until January 2005. From 1996 to 2003, Mr. McDowell was employed by HealthSouth Corporation, a provider of outpatient surgery, diagnostic imaging and rehabilitative healthcare services. Mr. McDowell is a physical therapist.
What is the salary of Glenn McDowell?
As the Chief Operating Officer - West of U.S. Physical Therapy, the total compensation of Glenn McDowell at U.S. Physical Therapy is $1,463,960. There are 3 executives at U.S. Physical Therapy getting paid more, with Christopher Reading having the highest compensation of $2,851,940.
How old is Glenn McDowell?
Glenn McDowell is 63, he's been the Chief Operating Officer - West of U.S. Physical Therapy since 2005. There are 8 older and 10 younger executives at U.S. Physical Therapy. The oldest executive at U.S. Physical Therapy, Inc. is Mark Brookner, 75, who is the Independent Director.
What's Glenn McDowell's mailing address?
Glenn's mailing address filed with the SEC is 1300 W SAM HOUSTON PKWY S, SUITE 300, HOUSTON, TX, 77042.
Insiders trading at U.S. Physical Therapy
Over the last 23 years, insiders at U.S. Physical Therapy have traded over $77,674,124 worth of U.S. Physical Therapy stock and bought 127,370 units worth $3,593,373 . The most active insiders traders include Bruce D Broussard, Roy W Spradlin, and Christopher J Reading. On average, U.S. Physical Therapy executives and independent directors trade stock every 22 days with the average trade being worth of $787,765. The most recent stock trade was executed by Kathleen A Gilmartin on 3 September 2024, trading 2,000 units of USPH stock currently worth $172,180.
What does U.S. Physical Therapy do?
u.s. physical therapy is a publicly held company that operates hundreds of outpatient physical and occupational therapy clinics in over 40 states. the company's clinics provide acute, post-operative, and preventative care for a variety of orthopedic and neurologic disorders including sports and work related injuries. the unique nature of the company is its operating structure - the company's clinics are developed and operated through partnerships with therapists who share in the clinic's profits. in addition to the therapist partnership model, u.s. physical therapy also buys into existing physical therapy practices.
What does U.S. Physical Therapy's logo look like?
Complete history of Mr. Dowell stock trades at U.S. Physical Therapy
U.S. Physical Therapy executives and stock owners
U.S. Physical Therapy executives and other stock owners filed with the SEC include:
-
Christopher Reading,
President, Chief Executive Officer, Director -
Lawrance McAfee,
Director -
Graham Reeve,
Chief Operating Officer - East -
Glenn McDowell,
Chief Operating Officer - West -
Christopher J. Reading,
Pres, CEO & Director -
Graham D. Reeve M.B.A., P.T.,
Chief Operating Officer of East -
Glenn D. McDowell,
Chief Operating Officer of West -
Carey P. Hendrickson,
Chief Financial Officer -
Reginald Swanson,
Director -
Clayton Trier,
Independent Director -
Harry Chapman,
Independent Director -
Edward Kuntz,
Independent Chairman of the Board -
Bernard Harris,
Independent Director -
Mark Brookner,
Independent Director -
Kathleen Gilmartin,
Independent Director -
Carey Hendrickson,
Chief Financial Officer -
Jason Anderson,
VP of HR -
Jayne Fleck Pool ATC, PT, SCS,
Sr. VP & Chief Compliance Officer -
Chadd Pence,
Sr. VP of Information Systems -
Jake Martinez,
Sr. VP of Fin. & Accounting -
Johnny J. Blanchard,
Assistant Controller -
Jon C. Bates,
VP & Corp. Controller -
Eric Joseph Williams,
Co-Chief Operating Officer - West -
Richard S. Binstein,
Exec. VP, Gen. Counsel & Sec. -
Marlin W Johnston,
Director -
Jerald L Pullins,
Director -
Eric Joseph Williams,
Co-Chief Operations Officer -
Regg E. Swanson,
-
Anne Motsenbocker,
-
Nancy Ham,
-
Bruce D Broussard,
Director -
James B Hoover,
Director -
Daniel C Arnold,
Director -
Albert L Rosen,
Director -
J Livingston Kosberg,
CEO and President -
Roy W Spradlin,
Chairman, President, CEO -
Michael Lewis Lang,
Sr. VP of Development -
Richard Binstein,
EVP Gen'l Counsel & Secretary